Cover Image

Topical application of methotrexate for inhibition of corneal angiogenesis

Purpose: Methotrexate (MTX) is a folic acid antagonist used in chemotherapy regimens. Additional therapeutic applications have been suggested based on effect as an immuno-modulating drug in systemic rheumatoid disease and associated uveitis. Since chronic inflammatory disease is often associated wit...

Full description

Saved in:
Bibliographic Details
Main Authors: Joussen, Antonia J. M. (Author) , Kruse, Friedrich E. (Author) , Völcker, Hans Eberhard (Author) , Kirchhof, Bernd (Author)
Format: Article (Journal)
Language:English
Published: [1999]
In: Graefe's archive for clinical and experimental ophthalmology
Year: 1999, Volume: 237, Issue: 11, Pages: 920-927
ISSN:1435-702X
DOI:10.1007/s004170050387
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s004170050387
Get full text
Author Notes:Antonia M. Joussen, Friedrich E. Kruse, Hans-Eberhard Völcker, Bernd Kirchhof

MARC

LEADER 00000caa a2200000 c 4500
001 1750245450
003 DE-627
005 20220819125427.0
007 cr uuu---uuuuu
008 210303s1999 xx |||||o 00| ||eng c
024 7 |a 10.1007/s004170050387  |2 doi 
035 |a (DE-627)1750245450 
035 |a (DE-599)KXP1750245450 
035 |a (OCoLC)1341397000 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Joussen, Antonia J. M.  |d 1971-  |e VerfasserIn  |0 (DE-588)115413073  |0 (DE-627)691298904  |0 (DE-576)289869110  |4 aut 
245 1 0 |a Topical application of methotrexate for inhibition of corneal angiogenesis  |c Antonia M. Joussen, Friedrich E. Kruse, Hans-Eberhard Völcker, Bernd Kirchhof 
264 1 |c [1999] 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 03.03.2021 
520 |a Purpose: Methotrexate (MTX) is a folic acid antagonist used in chemotherapy regimens. Additional therapeutic applications have been suggested based on effect as an immuno-modulating drug in systemic rheumatoid disease and associated uveitis. Since chronic inflammatory disease is often associated with a neovascular response, we investigated the use of MTX for treatment of corneal angiogenesis.· Methods: Neovascularizations were induced by fibroblast growth factor in a corneal pocket model. Vessels were examined biomicroscopically. MTX was applied topically to rabbit corneas in a concentration of 0.2 mg/day. MTX level was measured in aqueous humor and plasma. · Results: On day 9 the vascularized area was 12.0±6.9 mm2 in control eyes and significantly smaller, 2.2±1.86 mm2, in treated eyes. Treated animals showed no local side effects such as epithelial defects. Although therapeutic levels were measured in the aqueous humor, MTX could not be detected in the serum of treated animals.· Conclusion: The antiangiogenic mechanism of MTX might be due to inhibition of both macrophage invasion during early angiogenesis and endothelial cell proliferation. The high levels in the aqueous humor indicate a possible application of topical MTX for inflammations of the anterior segment of the eye. 
700 1 |a Kruse, Friedrich E.  |e VerfasserIn  |0 (DE-588)1111061238  |0 (DE-627)865472890  |0 (DE-576)163879737  |4 aut 
700 1 |a Völcker, Hans Eberhard  |d 1943-  |e VerfasserIn  |0 (DE-588)107745676X  |0 (DE-627)836712927  |0 (DE-576)446290807  |4 aut 
700 1 |a Kirchhof, Bernd  |e VerfasserIn  |0 (DE-588)172186781  |0 (DE-627)697101223  |0 (DE-576)133057437  |4 aut 
773 0 8 |i Enthalten in  |t Graefe's archive for clinical and experimental ophthalmology  |d Berlin : Springer, 1982  |g 237(1999), 11, Seite 920-927  |h Online-Ressource  |w (DE-627)253723728  |w (DE-600)1459159-5  |w (DE-576)072372931  |x 1435-702X  |7 nnas  |a Topical application of methotrexate for inhibition of corneal angiogenesis 
773 1 8 |g volume:237  |g year:1999  |g number:11  |g pages:920-927  |g extent:8  |a Topical application of methotrexate for inhibition of corneal angiogenesis 
856 4 0 |u https://doi.org/10.1007/s004170050387  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210303 
993 |a Article 
994 |a 1999 
998 |g 107745676X  |a Völcker, Hans Eberhard  |m 107745676X:Völcker, Hans Eberhard  |d 910000  |d 910900  |e 910000PV107745676X  |e 910900PV107745676X  |k 0/910000/  |k 1/910000/910900/  |p 3 
998 |g 1111061238  |a Kruse, Friedrich E.  |m 1111061238:Kruse, Friedrich E.  |d 910000  |d 910900  |e 910000PK1111061238  |e 910900PK1111061238  |k 0/910000/  |k 1/910000/910900/  |p 2 
999 |a KXP-PPN1750245450  |e 3880813892 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"title":[{"title_sort":"Graefe's archive for clinical and experimental ophthalmology","subtitle":"official organ of the Club Jules Gonin","title":"Graefe's archive for clinical and experimental ophthalmology"}],"pubHistory":["Volume 218, issue 1 (January 1982)-"],"part":{"volume":"237","text":"237(1999), 11, Seite 920-927","extent":"8","year":"1999","issue":"11","pages":"920-927"},"titleAlt":[{"title":"Archive for clinical and experimental ophthalmology"}],"disp":"Topical application of methotrexate for inhibition of corneal angiogenesisGraefe's archive for clinical and experimental ophthalmology","type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 07.04.2025","Ungezählte Beil.: Supplement"],"language":["eng"],"recId":"253723728","origin":[{"publisherPlace":"Berlin ; Heidelberg ; Berlin ; Heidelberg ; New York, NY","dateIssuedDisp":"1982-","publisher":"Springer ; Springer","dateIssuedKey":"1982"}],"id":{"issn":["1435-702X"],"zdb":["1459159-5"],"eki":["253723728"]},"physDesc":[{"extent":"Online-Ressource"}]}],"physDesc":[{"extent":"8 S."}],"name":{"displayForm":["Antonia M. Joussen, Friedrich E. Kruse, Hans-Eberhard Völcker, Bernd Kirchhof"]},"id":{"eki":["1750245450"],"doi":["10.1007/s004170050387"]},"origin":[{"dateIssuedKey":"1999","dateIssuedDisp":"[1999]"}],"language":["eng"],"recId":"1750245450","note":["Gesehen am 03.03.2021"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"role":"aut","display":"Joussen, Antonia J. M.","roleDisplay":"VerfasserIn","given":"Antonia J. M.","family":"Joussen"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Kruse, Friedrich E.","given":"Friedrich E.","family":"Kruse"},{"role":"aut","display":"Völcker, Hans Eberhard","roleDisplay":"VerfasserIn","given":"Hans Eberhard","family":"Völcker"},{"family":"Kirchhof","given":"Bernd","roleDisplay":"VerfasserIn","display":"Kirchhof, Bernd","role":"aut"}],"title":[{"title_sort":"Topical application of methotrexate for inhibition of corneal angiogenesis","title":"Topical application of methotrexate for inhibition of corneal angiogenesis"}]} 
SRT |a JOUSSENANTTOPICALAPP1999 

Similar Items